SCHEMBL4735945

SCHEMBL4735945

O=c1c(O)c(-c2cc(O)ccc2O)oc2ccc(O)cc12

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 10/20 0.71
▸ KMT2A Q03164 10/20 0.71
▸ CYP3A4 P08684 9/20 0.71
▸ HSD17B10 Q99714 9/20 0.71
▸ KDM4E B2RXH2 9/20 0.71
▸ MAPT P10636 9/20 0.71
▸ CYP2C9 P11712 6/20 0.71
▸ DHFR P00374 1/20 0.66
▸ CYP1A2 P05177 1/20 0.66
▸ KCNH2 Q12809 1/20 0.66
▸ CSNK2A2 P19784 3/20 0.63
▸ CSNK2B P67870 3/20 0.63
▸ CSNK2A1 P68400 3/20 0.63
▸ ALDH1A1 P00352 6/20 0.56
▸ HPGD P15428 6/20 0.56
▸ ALOX15 P16050 6/20 0.56
▸ CASP1 P29466 5/20 0.56
▸ CASP7 P55210 5/20 0.56
▸ TP53 P04637 5/20 0.56
▸ MAPK1 P28482 5/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL155995 0.90 MEN1 (0.71) MEN1KMT2ACYP3A4HSD17B10KDM4E
SCHEMBL5425962 0.89 MEN1 (0.66) MEN1KMT2ACYP3A4HSD17B10KDM4E
SCHEMBL505584 0.84 MEN1 (0.79) MEN1KMT2ACYP3A4HSD17B10KDM4E
SCHEMBL505415 0.84 DHFR (0.68) MEN1KMT2ACYP3A4HSD17B10KDM4E
SCHEMBL2281134 0.83 MEN1 (1.00) MEN1KMT2ACYP3A4HSD17B10KDM4E
SCHEMBL1627936 0.81 CYP3A4 (0.82) MEN1KMT2ACYP3A4HSD17B10KDM4E
SCHEMBL15456750 0.81 CYP3A4 (0.82) MEN1KMT2ACYP3A4HSD17B10KDM4E
SCHEMBL1628821 0.80 DHFR (1.00) MEN1KMT2ACYP3A4HSD17B10KDM4E
SCHEMBL2987776 0.79 ATP1A1 (0.61) MEN1KMT2ACYP3A4HSD17B10KDM4E
SCHEMBL24474227 0.78 MEN1 (0.83) MEN1KMT2ACYP3A4HSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008086400-A2 SIRTUIN-ACTIVATING COMPOUNDS OF ENHANCED BIOAVAILABILITY ISP INVESTMENTS INC. (US) 2008-07-17 — — WO claimed
WO-2008086400-A2 SIRTUIN-ACTIVATING COMPOUNDS OF ENHANCED BIOAVAILABILITY ISP INVESTMENTS INC. (US) 2008-07-17 — — WO disclosed
Send feedback